期刊文献+

辛伐他汀对急性冠脉综合征病人血清白细胞介素6及C反应蛋白变化的干预作用 被引量:5

下载PDF
导出
摘要 目的探讨辛伐他汀早期干预对急性冠脉综合征(ACS)病人血清白细胞介素-6(IL-6)和高敏C反应蛋白(hs-CRP)浓度的影响及他汀类治疗ACS的机制。方法分别测定50例ACS病人及30名正常对照者(NC组)的血清IL-6,hs-CRP水平;并将ACS组随机分成辛伐他汀组和常规组(每组25例),辛伐他汀组每晚加服辛伐他汀20mg,常规组服安慰剂,随访3周,再次测定血清IL-6及hs-CRP水平;分析比较组间及辛伐他汀治疗前后血清IL-6及hs-CRP水平。结果ACS组血清IL-6,hs-CRP水平均明显高于NC组(P<0.01)。治疗3周后,辛伐他汀组血清IL-6,hs-CRP浓度明显下降(P<0.01)。结论炎症在ACS的发生中起了重要的作用;辛伐他汀具有独立于降脂的抗炎作用,其抗炎作用在ACS病人早期治疗中可能具有重要意义。
出处 《中西医结合心脑血管病杂志》 2007年第7期633-634,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献10

  • 1Plutzky J.Inflammatory pathways in atherosclerosis and acute coronary syndromes[J].Am J Cardiol,2001,88:10K-15K.
  • 2Choussat R,Montalescot G,Collet JP,et al.Effect of prior exposure to chlamydia pneumoniae or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q wave acute myocardial infarction[J].Am J Cardiol,2000,86:379-384.
  • 3Mulvihill NT,Foley JB.Infammation in acute coronary syndromes[J].Heart,2002,87:201-204.
  • 4Torxewski J,Torzewski M,Bowyer DE,et al.C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries[J].Arterioscler Thromb Vasc Biol,1998,18:1386-1392.
  • 5黄炜,陈清枝,燕宪亮,王然,张颖.C-反应蛋白白细胞介素-6和肿瘤坏死因子-α在冠心病中的变化[J].临床心血管病杂志,2004,20(7):398-400. 被引量:29
  • 6Anderson JL,Carlquist JF,Muhlestein JB,et al.Evaluation of C-reactive protein,an inflammatory marker,and infectious serology as risk factors for coronary artery disease and myocardial infarction[J].JACC,1998,32:35-41.
  • 7赵晓燕,李泉生.血浆C反应蛋白与不稳定型心绞痛危险度分级关系的探讨[J].临床心血管病杂志,2003,19(5):277-279. 被引量:22
  • 8Haverkate F,Thompson SG,Pyke SD,et al.Production of C-reactive protein and risk of coronary events in stable and unstable angina:European concerted action or thrombosis and disabilities angina pectoris study group[J].Lancet,1997,349:462.
  • 9关瑜,张梦玺,袁洪,杨侃,杨季,王建刚.冠心病与肿瘤坏死因子、白细胞介素-6浓度关系的研究[J].临床心血管病杂志,1998,14(6):325-328. 被引量:21
  • 10温先勇,杭永伦,薛莉,邓正华.冠心病患者C-反应蛋白一氧化氮白细胞介素-6测定的临床意义[J].中国现代医学杂志,2003,13(1):69-70. 被引量:12

二级参考文献23

  • 1[1]Ross R. Atherosclerosis--An inflammatory disease. N Engl J Med, 1999, 340:115-126.
  • 2[2]Ridker P M, Cushman M, Stampfre M J, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation, 1998, 97:425-428.
  • 3[3]Anderson J L, Carlquist J F, Joseph B, et al. Evaluation of C-reactive protein , an inflammatory marker, and infectious serology as risk factor for coronary artery disease and myocardial infarction. JACC, 1988, 32:35-35.
  • 4[4]Braunwald E. Unstable angina, a classification. Circulation, 1989, 80:410-411.
  • 5[5]Haverkate F, Thompson S G, Pyke S D M, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European concerted action on thrombosis and disabilities angina pectoris study group. Lancet, 1997, 349:462-462.
  • 6[6]Liuzzo G, Biasucci L M, Gauinore J R, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med, 1994,331:417-424.
  • 7Li H,J Clin Invest,1995年,95卷,122页
  • 8Farmer J A,Gotto A M Jr. Dyslipidemia and other risk factors for coronary artery disease. In: Braunwald E,ed. Heart disease: A text book of cardiovascular medicine. 5th ed. Philadelphia: WB Saunders,1997. 1126-1126.
  • 9Maseri A. Inflammation,atherosclerosis and ischemia events- exploring the hidden side of the moon. N Engl J Med,1997,336: 1014-1016.
  • 10Torzewski J,Torzewski M,Bowyer D E,et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol,1998,18: 1386-1392.

共引文献78

同被引文献66

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部